騰邦國際(300178.SZ):騰邦集團及鍾百勝與大晉投資及史進簽署表決權委託解除協議
格隆匯11月18日丨騰邦國際(300178.SZ)公佈,公司控股股東騰邦集團有限公司(“騰邦集團”)及鍾百勝於2019年6月10日與深圳市大晉投資諮詢有限公司(“大晉投資”)簽署了《表決權委託協議》及《補充協議》。騰邦集團及鍾百勝將其所持有的公司的股票約1.7447億股(佔公司總股本的28.30%)表決權委託給大晉投資行使。
2019年11月18日,騰邦集團及鍾百勝與大晉投資及史進簽署了《表決權委託解除協議》,經各方合意,解除大晉投資及史進在原《表決權委託協議》及《補充協議》項下享有的標的股份所對應所有權利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.